In addition, a culture platform where cells are surrounded by an environment that more closely resembles the native ECM niche would improve the assessment of cell behavior in other areas of research such as drug development applications.
Therefore, we do not consider the implementation of the presented model as a potential bottleneck in a drug-development application.
These novel effects are probably caused by a novel mechanism involving phosphorylation of aminergic receptors and have clinical and drug-development applications.
In addition to drug development, their application as coloring agents, cosmetic materials, and dietary supplements have resulted in great interest in the mass production of flavonoids and stilbenes through various methodologies.
We propose that investigators consider this framework for model-based clinical oncology drug development for application in clinical protocol design and analyses.
Heterogeneity of response makes the traditional drug development and application process slow, costly and inefficient (Adams and Brantner, 2006; Yap et al, 2010).
Quantitative approaches have had significant impact in oncology drug development; their application to the interpretation of mechanistic nonclinical discovery data promises to continue providing significant value in the future.
In preclinical and clinical drug development, the applications of metabolomics have a considerable scope in the pharmaceutical industry, almost at each step from drug discovery to clinical development.
However, due to tremendous difficulties in developing highly selective inhibitors, most kinome targeted drug development programs restrict application to the oncology area [6].
The current trend toward building massive screening collections to support drug development, a special application of chemical biology, can limit their broader potential.
Nonetheless, inhibiting CCL2 and CCR2 is still a very active area for drug development with potential application for a multitude of important chronic human diseases.
